In the BioHarmony Drug Report Database

"Preview" Icon

Patiromer

Veltassa (patiromer) is a small molecule pharmaceutical. Patiromer was first approved as Veltassa on 2015-10-21. It is used to treat hyperkalemia in the USA. It has been approved in Europe to treat hyperkalemia. Veltassa’s patents are valid until 2033-10-08 (FDA).

 

Trade Name

 

Veltassa
 

Common Name

 

patiromer
 

ChEMBL ID

 

CHEMBL2107875
 

Indication

 

hyperkalemia
 

Drug Class

 

Polymers

Image (chem structure or protein)

Patiromer structure rendering